Circulating Biomarkers Associated with the Diagnosis and Prognosis of B-Cell Progenitor Acute Lymphoblastic Leukemia

Circulating Biomarkers Associated with the Diagnosis and Prognosis of B-Cell Progenitor Acute Lymphoblastic Leukemia

Acute lymphoblastic leukemia (ALL) is a hematological disease characterized by the dysfunction of the hematopoietic system that leads to arrest at a specific stage of stem cells development, suppressing the average production of cellular hematologic components. BCP-ALL is a neoplasm of the B-cell li...

Full description

Bibliographic Details
Main Authors:	Claudia Daniela Álvarez-Zúñiga, Idalia Garza-Veloz, Jacqueline Martínez-Rendón, Misael Ureño-Segura, Iván Delgado-Enciso, Margarita L. Martinez-Fierro
Format:	Article
Language:	English
Published:	MDPI AG 2023-08-01
Series:	Cancers
Subjects:	biomarkers circulating acute lymphoblastic leukemia BCP-ALL diagnosis prognosis
Online Access:	https://www.mdpi.com/2072-6694/15/16/4186

Similar Items

Neurofibromatosis Symptom-Lacking B-Cell Lineage Acute Lymphoblastic Leukemia with Only an <i>NF1</i> Gene Pathogenic Variant
by: Zehwan Kim, et al.
Published: (2023-04-01)

Pediatric Precursor B-Cell Lymphoblastic Malignancies: From Extramedullary to Medullary Involvement
by: Emma Kroeze, et al.
Published: (2022-08-01)

The role of microenvironment in the initiation and evolution of B-cell precursor acute lymphoblastic leukemia
by: Alicia Garcia-Gimenez, et al.
Published: (2023-03-01)

Inotuzumab ozogamicin in B-cell precursor acute lymphoblastic leukemia: efficacy, toxicity, and practical considerations
by: Jeremy D. Rubinstein, et al.
Published: (2023-08-01)

Engineering of CD19 Antibodies: A CD19-TRAIL Fusion Construct Specifically Induces Apoptosis in B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Cells In Vivo
by: Dorothee Winterberg, et al.
Published: (2021-06-01)

Common Presenting Signs and Symptoms in Children with Acute Lymphoblastic Leukemia
by: Ehsan Shahverdi, et al.
Published: (2020-08-01)

Adherence to Oral Chemotherapy in Acute Lymphoblastic Leukemia during Maintenance Therapy in Children, Adolescents, and Young Adults: A Systematic Review
by: Xiaopei L. Zeng, et al.
Published: (2023-01-01)

Analysis of non-alcoholic fatty liver disease during induction therapy for B-cell precursor acute lymphoblastic leukemia in children and adolescents
by: Hirozumi Sano, et al.
Published: (2024-01-01)

Added value of molecular karyotype in childhood acute lymphoblastic leukemia
by: Margaux Camuset, et al.
Published: (2023-12-01)

Conjoined Genes as Common Events in Childhood Acute Lymphoblastic Leukemia
by: Marco Severgnini, et al.
Published: (2022-07-01)

Genetic Biomarkers and Their Clinical Implications in B-Cell Acute Lymphoblastic Leukemia in Children
by: Monika Lejman, et al.
Published: (2022-03-01)

Study of Some Biochemical Parameters in Iraqi Children with Acute Lymphoblastic Leukemia
by: Baghdad Science Journal
Published: (2015-06-01)

Frontline Blinatumomab in Older Adults with Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia
by: Sandrine Niyongere, et al.
Published: (2020-06-01)

RAG1 co‐expression signature identifies ETV6‐RUNX1‐like B‐cell precursor acute lymphoblastic leukemia in children
by: Dongfeng Chen, et al.
Published: (2021-06-01)

Asparaginase in the Treatment of Acute Lymphoblastic Leukemia in Adults: Current Evidence and Place in Therapy
by: Juluri KR, et al.
Published: (2022-05-01)

Acute myelofibrosis superseding B‐lymphoblastic leukemia/lymphoma
by: Siba El Hussein, et al.
Published: (2023-11-01)

Mutational profiling of acute lymphoblastic leukemia with testicular relapse
by: Ling-Wen Ding, et al.
Published: (2017-03-01)

DNA methylation holds prognostic information in relapsed precursor B-cell acute lymphoblastic leukemia
by: Magnus Borssén, et al.
Published: (2018-03-01)

Monthly variation in diagnosis of acute lymphoblastic leukemia and survival outcome in children and adults: 15-year trends at a single center
by: José Carlos Jaime-Pérez, et al.
Published: (2022-07-01)

Childhood T-cell acute lymphoblastic leukemia in a single Latin American center: impact of improved treatment scheme and support therapy on survival
by: José Carlos Jaime-Pérez, et al.
Published: (2020-10-01)

Clinical and laboratory effects of exchange transfusion in pediatric acute lymphoblastic leukemia with hyperleukocytosis
by: Rasya Azka Lazuwardi, et al.
Published: (2023-11-01)

Relapse of acute lymphoblastic leukemia presenting as masquerade uveitis with hypopyon in a child
by: Obaidur Rehman, et al.
Published: (2022-01-01)

STAGE-DEPENDENT IMMUNOPATHOGENETIC FEATURES OF ACUTE NONLYMPHOBLASTIC AND ACUTE LYMPHOBLASTIC LEUKEMIA
by: O. V. Smirnova, et al.
Published: (2014-07-01)

Prognostic factors of children’s acute lymphoblastic leukemia therapy in Moscow—Berlin protocols
by: J. V. Roumiantseva, et al.
Published: (2022-11-01)

A single scalp nodule as the first presentation of acute lymphoblastic leukemia (KMT2A::MLLT3) in a healthy-appearing infant: a case report
by: Francesco Pellegrino, et al.
Published: (2023-12-01)

Adult B Lymphoblastic Leukemia with a Novel De Novo Chromosomal Translocation [Der(9)t(9;12)(p24;q12),-12]: A Case Report
by: P.K. Gadhia, et al.
Published: (2014-06-01)

t(1;4) translocation in a child with acute lymphoblastic leukemia: a case report
by: Chaimae El Mahdaoui, et al.
Published: (2023-12-01)

T Regulatory Cells Frequency During Maintenance Phase Chemotherapy for Pediatric Acute Lymphoblastic Leukemia
by: Marina Nayeli Medina-Rosales, et al.
Published: (2020-03-01)

Outcomes and adverse events in older acute lymphoblastic Leukemia patients treated with a pediatric-inspired protocol with Pegylated or native Asparaginase
by: Maria Agustina Perusini, et al.
Published: (2024-12-01)

A phase 2 and pharmacological study of sapanisertib in patients with relapsed and/or refractory acute lymphoblastic leukemia
by: Aref Al‐Kali, et al.
Published: (2023-12-01)

Pharmacogenetics of pediatric acute lymphoblastic leukemia in Uruguay: adverse events related to induction phase drugs
by: Gabriela Burgueño-Rodríguez, et al.
Published: (2023-11-01)

Fast, In Vivo Model for Drug-Response Prediction in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia
by: Anton Gauert, et al.
Published: (2020-07-01)

Multi-Faceted Effects of ST6Gal1 Expression on Precursor B-Lineage Acute Lymphoblastic Leukemia
by: Mingfeng Zhang, et al.
Published: (2022-03-01)

Early T-Cell Precursor Acute Lymphoblastic Leukemia: Diagnosis, Updates in Molecular Pathogenesis, Management, and Novel Therapies
by: Chun-fung Sin, et al.
Published: (2021-11-01)

Peg-asparaginase associated toxicities in children with acute lymphoblastic leukemia: A single-center cross-sectional study
by: Sameh Awwad, et al.
Published: (2024-03-01)

Metabolic Profiling as an Approach to Differentiate T-Cell Acute Lymphoblastic Leukemia Cell Lines Belonging to the Same Genetic Subgroup
by: Husam B. R. Alabed, et al.
Published: (2024-03-01)

Autophagy Regulates VDAC3 Ubiquitination by FBXW7 to Promote Erastin-Induced Ferroptosis in Acute Lymphoblastic Leukemia
by: Ting Zhu, et al.
Published: (2021-11-01)

The contribution of XRCC3 genotypes to childhood acute lymphoblastic leukemia
by: Pei JS, et al.
Published: (2018-11-01)

MiRNAs in Hematopoiesis and Acute Lymphoblastic Leukemia
by: Diana Karen Mendiola-Soto, et al.
Published: (2023-03-01)

Novel germline TRAF3IP3 mutation in a dyad with familial acute B lymphoblastic leukemia
by: Lauren Pommert, et al.
Published: (2021-06-01)